Neuronal ceroid lipofuscinosis type 2 (CLN2) disease is an ultrarare, severe, and rapidly progressing lysosomal storage disorder, with a global […]
Conventional central line insertion technique using the landmark method to identify the target vein for catheter insertion does not account
Canada’s Drug Agency (CDA-AMC) recommends that Keytruda be reimbursed by public drug plans for the treatment of primary advanced or
Antiviral medications for influenza can be used after exposure but before symptom onset to reduce the occurrence of symptomatic and
Influenza is a major public health concern, causing significant illness, death, economic challenges, and pandemic potential. This underscores the need
Canada’s Drug Agency (CDA-AMC) recommends that Sarclisa be reimbursed by public drug plans for the treatment of patients with newly
Registration No: 771800548 Contact Number : +91-8249516996
